BRCA2 and cancer: Heterozygous carriers of pathogenic variants in FA pathway genes—most notably FANCD1/BRCA2 and FANCN/PALB2—are at increased risk for various cancers, particularly breast, ovarian, and pancreatic malignancies [15,35].